Pharmacogenotyping in pharmaceutical care
Project funded by own resources
Project title Pharmacogenotyping in pharmaceutical care
Principal Investigator(s) Hersberger, Kurt
Co-Investigator(s) Jeiziner, Chiara
Meyer zu Schwabedissen, Henriette
Suter-Zimmermann, Katja
Lampert, Markus Leopold
Stäuble, Céline
Organisation / Research unit Departement Pharmazeutische Wissenschaften / Pharmaceutical Care (Hersberger)
Project start 01.08.2018
Probable end 31.07.2022
Status Active

With the developing knowledge on genetic variants influencing pharmacokinetics and/or
pharmacodynamics of frequently applied drugs, multiple providers are now offering PGx
assessment using DNA isolated from buccal swaps. One product is
Stratipharm ( that offers genotyping (based on the DNA obtained from a buccal swap) in combination with sophisticated evidence-based interpretation of the genotype. The test system covers almost 100 genetic variants corresponding to 30 genes of pharmacogenetic relevance.

In an observational study over 3 years the primary objective is the compilation of case reports, where pharmacogenetic testing is applied to determine the hereditable component of the patient’s susceptibility to experience therapy failure and/or adverse drug reactions. The experience with the compiled cases will be basis for the development of a reliable standard of procedure for pharmacogenetic testing in the community pharmacy.

Financed by University funds
Other funds

MCSS v5.8 PRO. 0.627 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |